Management expects to "soon submit the Q-sub request on approvability of the CardiAMP system to FDA Center for Biologics Evaluation and Research." Altman expects a 45-day turnaround from FDA for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results